Literature DB >> 3522580

Thrombin-like enzyme from the venom of Bitis gabonica. Purification, properties, and coagulant actions.

H Pirkle, I Theodor, D Miyada, G Simmons.   

Abstract

Gabonase, an enzyme which acts on fibrinogen and factor XIII in uniquely thrombin-like ways, was purified to electrophoretic homogeneity from the venom of Bitis gabonica. On sodium dodecyl sulfate-polyacrylamide electrophoresis, the reduced protein behaved as a single chain with Mr = 30,600. The enzyme contains 20.6% carbohydrate, no free sulfhydryl groups and hence, from amino acid analysis, five disulfide bonds. Its extinction coefficient (E1%1cm) at 280 nm is 9.6. Its pI is 5.3. Gabonase has an active serine residue, is inactivated by phenylmethanesulfonyl fluoride, and has an active histidine which reacts with the chloromethyl ketone of tosyl-L-lysine. Its NH2-terminal amino acid sequence (Val-Val-Gly-Gly-Ala-Glu-Cys-Lys-Ile-Asp-Gly-His-Arg-Cys-Leu-Ala-Leu-Leu -Tyr-) is homologous to the B chain of thrombin. The activity of the enzyme is stabilized by calcium ion. It exhibits strong N alpha-p-tosyl-L-arginine methyl esterase activity, hydrolyzes tripeptide nitroanilide derivatives weakly or not at all, and cleaves no peptide bonds in insulin, glucagon, or the S peptide of ribonuclease. Gabonase clots fibrinogen with a specific activity of 45 NIH thrombin-equivalent units/mg, releasing both fibrinopeptides A and B and showing substrate inhibition at fibrinogen concentrations of 3 mg/ml or greater. The enzyme also activates factor XIII. It is not inactivated by either heparin or hirudin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3522580

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Snake venoms.

Authors:  F S Markland
Journal:  Drugs       Date:  1997       Impact factor: 9.546

2.  A novel serine protease from the snake venom of Agkistrodon blomhoffii ussurensis.

Authors:  Shuqing Liu; Ming-Zhong Sun; Changkai Sun; Baochang Zhao; Frederick T Greenaway; Qingyin Zheng
Journal:  Toxicon       Date:  2008-09-09       Impact factor: 3.033

3.  Purification and functional characterisation of rhinocerase, a novel serine protease from the venom of Bitis gabonica rhinoceros.

Authors:  Sakthivel Vaiyapuri; Robert A Harrison; Andrew B Bicknell; Jonathan M Gibbins; Gail Hutchinson
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

4.  Bitis gabonica (Gaboon viper) snake venom gland: toward a catalog for the full-length transcripts (cDNA) and proteins.

Authors:  Ivo M B Francischetti; Van My-Pham; Jim Harrison; Mark K Garfield; José M C Ribeiro
Journal:  Gene       Date:  2004-08-04       Impact factor: 3.688

Review 5.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

6.  Efficacy and Limitations of Chemically Diverse Small-Molecule Enzyme-Inhibitors against the Synergistic Coagulotoxic Activities of Bitis Viper Venoms.

Authors:  Nicholas J Youngman; Matthew R Lewin; Rebecca Carter; Arno Naude; Bryan G Fry
Journal:  Molecules       Date:  2022-03-07       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.